 Bennett Davenport
Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chikungunya virus | 12 | 2025 | 78 | 2.380 |
Why?
| | CD8-Positive T-Lymphocytes | 10 | 2025 | 917 | 2.240 |
Why?
| | Chikungunya Fever | 11 | 2025 | 77 | 1.960 |
Why?
| | Immunologic Memory | 6 | 2025 | 369 | 1.930 |
Why?
| | Lymphocytic choriomeningitis virus | 4 | 2019 | 24 | 1.380 |
Why?
| | Chemokines | 4 | 2020 | 229 | 0.870 |
Why?
| | Epitopes, T-Lymphocyte | 3 | 2021 | 187 | 0.860 |
Why?
| | Lymph Nodes | 5 | 2024 | 493 | 0.840 |
Why?
| | Viral Envelope Proteins | 4 | 2025 | 84 | 0.780 |
Why?
| | CD4-Positive T-Lymphocytes | 5 | 2025 | 1092 | 0.710 |
Why?
| | Lymphocytic Choriomeningitis | 2 | 2018 | 14 | 0.710 |
Why?
| | Arenaviridae Infections | 2 | 2019 | 8 | 0.690 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 107 | 0.660 |
Why?
| | Alphavirus Infections | 4 | 2021 | 44 | 0.640 |
Why?
| | Joints | 1 | 2020 | 105 | 0.620 |
Why?
| | Leishmania major | 1 | 2018 | 8 | 0.610 |
Why?
| | Leishmaniasis, Cutaneous | 1 | 2018 | 14 | 0.600 |
Why?
| | Aging | 2 | 2019 | 1866 | 0.600 |
Why?
| | Mental Recall | 1 | 2019 | 204 | 0.570 |
Why?
| | Virulence Factors | 1 | 2018 | 167 | 0.540 |
Why?
| | Superoxide Dismutase | 1 | 2018 | 346 | 0.510 |
Why?
| | Mice | 24 | 2025 | 17843 | 0.490 |
Why?
| | Cytokines | 3 | 2020 | 2095 | 0.480 |
Why?
| | Animals | 33 | 2025 | 37011 | 0.450 |
Why?
| | Viremia | 3 | 2025 | 138 | 0.440 |
Why?
| | Phagocytes | 2 | 2025 | 100 | 0.420 |
Why?
| | Mice, Inbred C57BL | 13 | 2025 | 5792 | 0.390 |
Why?
| | Antiviral Agents | 3 | 2025 | 740 | 0.380 |
Why?
| | Macrophages | 2 | 2022 | 1548 | 0.370 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2022 | 24 | 0.340 |
Why?
| | Antibodies, Viral | 3 | 2025 | 623 | 0.330 |
Why?
| | Mice, Knockout | 7 | 2025 | 3020 | 0.330 |
Why?
| | Adaptive Immunity | 3 | 2020 | 164 | 0.320 |
Why?
| | Receptors, Immunologic | 2 | 2021 | 223 | 0.310 |
Why?
| | Mice, Inbred BALB C | 3 | 2020 | 1271 | 0.290 |
Why?
| | Peromyscus | 2 | 2004 | 7 | 0.290 |
Why?
| | Antigen Presentation | 2 | 2025 | 216 | 0.270 |
Why?
| | Disease Models, Animal | 7 | 2025 | 4295 | 0.260 |
Why?
| | Mice, Transgenic | 7 | 2025 | 2182 | 0.260 |
Why?
| | Insulin-Secreting Cells | 2 | 2022 | 372 | 0.250 |
Why?
| | Encephalomyelitis, Equine | 1 | 2025 | 3 | 0.240 |
Why?
| | Encephalitis Virus, Eastern Equine | 1 | 2025 | 4 | 0.240 |
Why?
| | Antibodies, Neutralizing | 2 | 2025 | 282 | 0.240 |
Why?
| | Cysteine Proteases | 1 | 2025 | 7 | 0.240 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 2025 | 49 | 0.230 |
Why?
| | Molecular Probes | 1 | 2025 | 36 | 0.230 |
Why?
| | Clodronic Acid | 1 | 2025 | 17 | 0.230 |
Why?
| | Orthomyxoviridae Infections | 1 | 2025 | 75 | 0.230 |
Why?
| | Immune Evasion | 1 | 2025 | 58 | 0.230 |
Why?
| | Immunization | 3 | 2024 | 414 | 0.220 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 3 | 2014 | 337 | 0.210 |
Why?
| | Virulence | 3 | 2021 | 266 | 0.210 |
Why?
| | Ross River virus | 2 | 2021 | 23 | 0.210 |
Why?
| | NADPH Oxidases | 1 | 2024 | 110 | 0.210 |
Why?
| | Kupffer Cells | 2 | 2021 | 50 | 0.200 |
Why?
| | Methionine | 1 | 2024 | 159 | 0.200 |
Why?
| | Liposomes | 1 | 2025 | 221 | 0.200 |
Why?
| | Interferon Type I | 2 | 2021 | 142 | 0.200 |
Why?
| | Lectins, C-Type | 2 | 2020 | 72 | 0.200 |
Why?
| | Lymphoid Tissue | 2 | 2019 | 75 | 0.190 |
Why?
| | Salmonella | 1 | 2022 | 60 | 0.190 |
Why?
| | Viral Vaccines | 1 | 2022 | 98 | 0.180 |
Why?
| | Virus Replication | 2 | 2022 | 480 | 0.170 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2021 | 429 | 0.170 |
Why?
| | Receptors, Mitogen | 1 | 2020 | 9 | 0.170 |
Why?
| | Proteome | 1 | 2025 | 474 | 0.170 |
Why?
| | Transcriptional Activation | 1 | 2022 | 379 | 0.170 |
Why?
| | Gene Expression Regulation | 3 | 2019 | 2615 | 0.160 |
Why?
| | O'nyong-nyong Virus | 1 | 2019 | 4 | 0.160 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2019 | 27 | 0.160 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2022 | 328 | 0.160 |
Why?
| | Lymphocyte Activation | 4 | 2025 | 1150 | 0.160 |
Why?
| | Adoptive Transfer | 1 | 2020 | 224 | 0.160 |
Why?
| | Arthritis | 1 | 2020 | 95 | 0.160 |
Why?
| | Parasite Load | 1 | 2018 | 8 | 0.150 |
Why?
| | Leishmania donovani | 1 | 2018 | 12 | 0.150 |
Why?
| | Lung | 2 | 2025 | 4066 | 0.150 |
Why?
| | Gene Deletion | 2 | 2018 | 393 | 0.150 |
Why?
| | Antigens, Viral | 1 | 2018 | 180 | 0.140 |
Why?
| | Acute Disease | 1 | 2020 | 1008 | 0.140 |
Why?
| | Dendritic Cells | 1 | 2021 | 488 | 0.140 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2018 | 93 | 0.140 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2019 | 765 | 0.140 |
Why?
| | Nuclear Proteins | 2 | 2022 | 710 | 0.140 |
Why?
| | Cells, Cultured | 4 | 2018 | 4206 | 0.130 |
Why?
| | Glucose | 2 | 2022 | 1018 | 0.130 |
Why?
| | Oxidative Stress | 2 | 2022 | 1307 | 0.130 |
Why?
| | TRPM Cation Channels | 2 | 2008 | 82 | 0.130 |
Why?
| | T-Lymphocyte Subsets | 2 | 2011 | 425 | 0.130 |
Why?
| | Bacterial Proteins | 1 | 2022 | 889 | 0.120 |
Why?
| | Membrane Proteins | 1 | 2022 | 1167 | 0.120 |
Why?
| | Cell Survival | 1 | 2018 | 1122 | 0.120 |
Why?
| | Monocytes | 1 | 2017 | 568 | 0.110 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2018 | 720 | 0.110 |
Why?
| | Acute Lung Injury | 1 | 2017 | 288 | 0.110 |
Why?
| | Chronic Disease | 1 | 2020 | 1790 | 0.110 |
Why?
| | Cell Movement | 1 | 2018 | 972 | 0.110 |
Why?
| | Breast Neoplasms | 1 | 2025 | 2249 | 0.100 |
Why?
| | Antibodies, Monoclonal | 1 | 2019 | 1428 | 0.100 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2013 | 173 | 0.100 |
Why?
| | Vaccination | 1 | 2021 | 1398 | 0.100 |
Why?
| | Lung Neoplasms | 1 | 2025 | 2494 | 0.090 |
Why?
| | Neutrophils | 1 | 2017 | 1238 | 0.090 |
Why?
| | Epithelial Cells | 1 | 2017 | 1099 | 0.090 |
Why?
| | Male | 6 | 2020 | 67718 | 0.090 |
Why?
| | MicroRNAs | 1 | 2017 | 704 | 0.090 |
Why?
| | Epitopes | 2 | 2025 | 481 | 0.080 |
Why?
| | Muscle, Skeletal | 1 | 2020 | 1701 | 0.080 |
Why?
| | Transcription Factors | 1 | 2018 | 1717 | 0.080 |
Why?
| | T-Lymphocytes | 3 | 2019 | 1999 | 0.080 |
Why?
| | Immunodominant Epitopes | 1 | 2009 | 28 | 0.080 |
Why?
| | Cell Proliferation | 3 | 2025 | 2482 | 0.080 |
Why?
| | Parkinsonian Disorders | 1 | 2008 | 35 | 0.070 |
Why?
| | Mutant Proteins | 1 | 2008 | 101 | 0.070 |
Why?
| | Humans | 18 | 2025 | 137514 | 0.070 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2008 | 87 | 0.070 |
Why?
| | Viral Load | 2 | 2021 | 462 | 0.070 |
Why?
| | Endothelial Cells | 2 | 2024 | 780 | 0.070 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2004 | 152 | 0.070 |
Why?
| | Female | 5 | 2025 | 73162 | 0.070 |
Why?
| | RNA, Viral | 2 | 2021 | 653 | 0.070 |
Why?
| | Cloning, Molecular | 2 | 2004 | 536 | 0.060 |
Why?
| | Hepatocyte Nuclear Factor 1-alpha | 1 | 2025 | 17 | 0.060 |
Why?
| | Killer Cells, Natural | 2 | 2019 | 446 | 0.060 |
Why?
| | Heparitin Sulfate | 1 | 2025 | 50 | 0.060 |
Why?
| | Orthobunyavirus | 1 | 2025 | 6 | 0.060 |
Why?
| | Cysteine Endopeptidases | 1 | 2025 | 72 | 0.060 |
Why?
| | Bunyaviridae Infections | 1 | 2025 | 12 | 0.060 |
Why?
| | Peptide Fragments | 1 | 2009 | 708 | 0.060 |
Why?
| | Hemocyanins | 1 | 2004 | 62 | 0.060 |
Why?
| | Immune Sera | 1 | 2004 | 88 | 0.060 |
Why?
| | Sulfones | 1 | 2025 | 110 | 0.060 |
Why?
| | Antigen-Presenting Cells | 1 | 2004 | 156 | 0.050 |
Why?
| | Mutation | 3 | 2025 | 3964 | 0.050 |
Why?
| | Anaerobiosis | 1 | 2024 | 63 | 0.050 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2004 | 137 | 0.050 |
Why?
| | Insulin | 2 | 2018 | 2398 | 0.050 |
Why?
| | Cell Differentiation | 2 | 2025 | 1979 | 0.050 |
Why?
| | B-Lymphocytes | 2 | 2019 | 847 | 0.050 |
Why?
| | Bone Marrow Cells | 1 | 2004 | 313 | 0.050 |
Why?
| | Respiration | 1 | 2024 | 198 | 0.050 |
Why?
| | Interleukin-2 | 1 | 2004 | 456 | 0.050 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2004 | 368 | 0.050 |
Why?
| | Coculture Techniques | 1 | 2023 | 240 | 0.050 |
Why?
| | Neoplasm Metastasis | 1 | 2025 | 659 | 0.050 |
Why?
| | Salmonella typhimurium | 1 | 2024 | 182 | 0.050 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2022 | 57 | 0.050 |
Why?
| | Interferon Regulatory Factors | 1 | 2022 | 37 | 0.050 |
Why?
| | Phenylalanine | 1 | 2022 | 68 | 0.050 |
Why?
| | Binding Sites | 1 | 2025 | 1310 | 0.050 |
Why?
| | Feedback | 1 | 2022 | 174 | 0.050 |
Why?
| | Alphavirus | 1 | 2021 | 21 | 0.050 |
Why?
| | HeLa Cells | 1 | 2023 | 640 | 0.050 |
Why?
| | Vaccines, Attenuated | 1 | 2022 | 131 | 0.050 |
Why?
| | Amino Acids | 1 | 2025 | 503 | 0.040 |
Why?
| | Cell Line, Tumor | 2 | 2020 | 3420 | 0.040 |
Why?
| | Mice, Mutant Strains | 1 | 2021 | 300 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2025 | 778 | 0.040 |
Why?
| | Viral Nonstructural Proteins | 1 | 2021 | 65 | 0.040 |
Why?
| | Protein Domains | 1 | 2022 | 290 | 0.040 |
Why?
| | Viral Tropism | 1 | 2019 | 30 | 0.040 |
Why?
| | Cricetinae | 1 | 2020 | 288 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 619 | 0.040 |
Why?
| | Venules | 1 | 2018 | 14 | 0.040 |
Why?
| | Chemokine CCL21 | 1 | 2018 | 14 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2021 | 309 | 0.040 |
Why?
| | Disease Outbreaks | 1 | 2022 | 376 | 0.040 |
Why?
| | Organelle Biogenesis | 1 | 2018 | 15 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 367 | 0.040 |
Why?
| | Conserved Sequence | 2 | 2009 | 239 | 0.040 |
Why?
| | Interferon Regulatory Factor-7 | 1 | 2017 | 5 | 0.040 |
Why?
| | Ovalbumin | 1 | 2018 | 183 | 0.040 |
Why?
| | Tissue Culture Techniques | 1 | 2018 | 77 | 0.040 |
Why?
| | Interferon Regulatory Factor-3 | 1 | 2017 | 17 | 0.040 |
Why?
| | Stromal Cells | 1 | 2018 | 111 | 0.040 |
Why?
| | Heparin-binding EGF-like Growth Factor | 1 | 2017 | 16 | 0.040 |
Why?
| | Antigens, Ly | 1 | 2017 | 44 | 0.040 |
Why?
| | Mitochondrial Dynamics | 1 | 2018 | 40 | 0.040 |
Why?
| | Receptors, CCR2 | 1 | 2017 | 40 | 0.040 |
Why?
| | RNA Transport | 1 | 2017 | 23 | 0.030 |
Why?
| | Diphtheria Toxin | 1 | 2017 | 65 | 0.030 |
Why?
| | Mutation, Missense | 1 | 2019 | 338 | 0.030 |
Why?
| | Spleen | 1 | 2019 | 516 | 0.030 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2017 | 99 | 0.030 |
Why?
| | Luminescent Proteins | 1 | 2018 | 178 | 0.030 |
Why?
| | Protein Subunits | 1 | 2018 | 238 | 0.030 |
Why?
| | Lysine | 1 | 2019 | 297 | 0.030 |
Why?
| | Cadaver | 1 | 2018 | 319 | 0.030 |
Why?
| | Magnesium | 2 | 2008 | 159 | 0.030 |
Why?
| | Cell Degranulation | 1 | 2016 | 42 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2017 | 329 | 0.030 |
Why?
| | Granzymes | 1 | 2016 | 49 | 0.030 |
Why?
| | RNA Interference | 1 | 2018 | 464 | 0.030 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2016 | 225 | 0.030 |
Why?
| | Cell Communication | 1 | 2017 | 313 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2018 | 665 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2018 | 684 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2021 | 832 | 0.030 |
Why?
| | Cellular Senescence | 1 | 2016 | 188 | 0.030 |
Why?
| | V(D)J Recombination | 1 | 2014 | 8 | 0.030 |
Why?
| | Cell Membrane | 2 | 2008 | 751 | 0.030 |
Why?
| | Thymus Gland | 1 | 2014 | 313 | 0.030 |
Why?
| | Amino Acid Sequence | 2 | 2008 | 2146 | 0.020 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2009 | 3708 | 0.020 |
Why?
| | B7-2 Antigen | 1 | 2011 | 27 | 0.020 |
Why?
| | CD28 Antigens | 1 | 2011 | 53 | 0.020 |
Why?
| | B7-1 Antigen | 1 | 2011 | 58 | 0.020 |
Why?
| | Viruses | 1 | 2013 | 112 | 0.020 |
Why?
| | Molecular Sequence Data | 2 | 2008 | 2901 | 0.020 |
Why?
| | Nanoparticles | 1 | 2017 | 484 | 0.020 |
Why?
| | Pneumonia | 1 | 2017 | 638 | 0.020 |
Why?
| | Transcriptome | 1 | 2016 | 974 | 0.020 |
Why?
| | Rats | 1 | 2018 | 5676 | 0.020 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 2009 | 51 | 0.020 |
Why?
| | Amino Acids, Diamino | 1 | 2008 | 1 | 0.020 |
Why?
| | Adenosine Diphosphate Ribose | 1 | 2008 | 7 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2013 | 1185 | 0.020 |
Why?
| | Guam | 1 | 2008 | 13 | 0.020 |
Why?
| | Epitope Mapping | 1 | 2009 | 62 | 0.020 |
Why?
| | Hybridomas | 1 | 2009 | 237 | 0.020 |
Why?
| | Ion Channel Gating | 1 | 2008 | 95 | 0.020 |
Why?
| | Leucine | 1 | 2008 | 111 | 0.020 |
Why?
| | Proline | 1 | 2008 | 80 | 0.020 |
Why?
| | Signal Transduction | 1 | 2021 | 5096 | 0.020 |
Why?
| | Mice, Inbred NOD | 1 | 2009 | 601 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2008 | 320 | 0.020 |
Why?
| | Calcium Signaling | 1 | 2008 | 253 | 0.020 |
Why?
| | Inflammation | 1 | 2017 | 2837 | 0.020 |
Why?
| | Bacteria | 1 | 2013 | 858 | 0.020 |
Why?
| | Autoantigens | 1 | 2009 | 429 | 0.020 |
Why?
| | Genetic Complementation Test | 1 | 2005 | 66 | 0.020 |
Why?
| | Temperature | 1 | 2008 | 680 | 0.010 |
Why?
| | Evolution, Molecular | 1 | 2008 | 488 | 0.010 |
Why?
| | Cell Division | 1 | 2005 | 795 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2004 | 269 | 0.010 |
Why?
| | Models, Molecular | 1 | 2008 | 1586 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2004 | 345 | 0.010 |
Why?
| | Protein Binding | 1 | 2009 | 2229 | 0.010 |
Why?
| | Calcium | 1 | 2008 | 1233 | 0.010 |
Why?
| | Interleukins | 1 | 2004 | 251 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 974 | 0.010 |
Why?
| | Homeostasis | 1 | 2005 | 622 | 0.010 |
Why?
| | Phosphorylation | 1 | 2005 | 1762 | 0.010 |
Why?
| | Cell Line | 1 | 2005 | 2852 | 0.010 |
Why?
|
|
Davenport's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|